Enanta Pharmaceuticals, Inc. (ENTA)
12.63
+0.75
(+6.31%)
USD |
NASDAQ |
Sep 28, 16:00
12.63
0.00 (0.00%)
After-Hours: 16:43
Enanta Pharmaceuticals Cash from Operations (Annual) : -19.27M for Sept. 30, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| September 30, 2025 | -19.27M |
| September 30, 2024 | -78.76M |
| September 30, 2023 | -103.15M |
| September 30, 2022 | -84.78M |
| September 30, 2021 | -70.00M |
| September 30, 2020 | 7.088M |
| September 30, 2019 | 71.42M |
| September 30, 2018 | 29.22M |
| Date | Value |
|---|---|
| September 30, 2017 | 52.65M |
| September 30, 2016 | 35.81M |
| September 30, 2015 | 76.67M |
| September 30, 2014 | 20.18M |
| September 30, 2013 | 10.65M |
| September 30, 2012 | 22.62M |
| September 30, 2011 | 24.02M |
| September 30, 2010 | -10.18M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Perspective Therapeutics, Inc. | -82.48M |
| Coherus Oncology, Inc. | -138.51M |
| BridgeBio Pharma, Inc. | -445.91M |
| RenovoRx, Inc. | -10.97M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |